These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation. Ho CY; Mobley BC; Gordish-Dressman H; VandenBussche CJ; Mason GE; Bornhorst M; Esbenshade AJ; Tehrani M; Orr BA; LaFrance DR; Devaney JM; Meltzer BW; Hofherr SE; Burger PC; Packer RJ; Rodriguez FJ Acta Neuropathol; 2015 Oct; 130(4):575-85. PubMed ID: 26264609 [TBL] [Abstract][Full Text] [Related]
3. Pediatric low-grade gliomas can be molecularly stratified for risk. Yang RR; Aibaidula A; Wang WW; Chan AK; Shi ZF; Zhang ZY; Chan DTM; Poon WS; Liu XZ; Li WC; Zhang RQ; Li YX; Chung NY; Chen H; Wu J; Zhou L; Li KK; Ng HK Acta Neuropathol; 2018 Oct; 136(4):641-655. PubMed ID: 29948154 [TBL] [Abstract][Full Text] [Related]
4. Molecular fingerprinting reflects different histotypes and brain region in low grade gliomas. Mascelli S; Barla A; Raso A; Mosci S; Nozza P; Biassoni R; Morana G; Huber M; Mircean C; Fasulo D; Noy K; Wittemberg G; Pignatelli S; Piatelli G; Cama A; Garré ML; Capra V; Verri A BMC Cancer; 2013 Aug; 13():387. PubMed ID: 23947815 [TBL] [Abstract][Full Text] [Related]
5. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification. Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961 [TBL] [Abstract][Full Text] [Related]
6. Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors. Fina F; Barets D; Colin C; Bouvier C; Padovani L; Nanni-Metellus I; Ouafik L; Scavarda D; Korshunov A; Jones DT; Figarella-Branger D Oncotarget; 2017 Jan; 8(2):2104-2113. PubMed ID: 27791984 [TBL] [Abstract][Full Text] [Related]
7. An integrative molecular and genomic analysis of pediatric hemispheric low-grade gliomas: an update. Lassaletta A; Zapotocky M; Bouffet E; Hawkins C; Tabori U Childs Nerv Syst; 2016 Oct; 32(10):1789-97. PubMed ID: 27659822 [TBL] [Abstract][Full Text] [Related]
8. BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma. Mistry M; Zhukova N; Merico D; Rakopoulos P; Krishnatry R; Shago M; Stavropoulos J; Alon N; Pole JD; Ray PN; Navickiene V; Mangerel J; Remke M; Buczkowicz P; Ramaswamy V; Guerreiro Stucklin A; Li M; Young EJ; Zhang C; Castelo-Branco P; Bakry D; Laughlin S; Shlien A; Chan J; Ligon KL; Rutka JT; Dirks PB; Taylor MD; Greenberg M; Malkin D; Huang A; Bouffet E; Hawkins CE; Tabori U J Clin Oncol; 2015 Mar; 33(9):1015-22. PubMed ID: 25667294 [TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological and molecular characteristics of pediatric gliomas: analysis of 111 cases]. Xu H; Niu HL; Wang FH; Xu XK; Wang W; Yuan L; Chen K; Gao Q; Li LP; Xia JQ; Guo ZM Zhonghua Bing Li Xue Za Zhi; 2024 Sep; 53(9):922-928. PubMed ID: 39231745 [No Abstract] [Full Text] [Related]
10. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas. Lassaletta A; Zapotocky M; Mistry M; Ramaswamy V; Honnorat M; Krishnatry R; Guerreiro Stucklin A; Zhukova N; Arnoldo A; Ryall S; Ling C; McKeown T; Loukides J; Cruz O; de Torres C; Ho CY; Packer RJ; Tatevossian R; Qaddoumi I; Harreld JH; Dalton JD; Mulcahy-Levy J; Foreman N; Karajannis MA; Wang S; Snuderl M; Nageswara Rao A; Giannini C; Kieran M; Ligon KL; Garre ML; Nozza P; Mascelli S; Raso A; Mueller S; Nicolaides T; Silva K; Perbet R; Vasiljevic A; Faure Conter C; Frappaz D; Leary S; Crane C; Chan A; Ng HK; Shi ZF; Mao Y; Finch E; Eisenstat D; Wilson B; Carret AS; Hauser P; Sumerauer D; Krskova L; Larouche V; Fleming A; Zelcer S; Jabado N; Rutka JT; Dirks P; Taylor MD; Chen S; Bartels U; Huang A; Ellison DW; Bouffet E; Hawkins C; Tabori U J Clin Oncol; 2017 Sep; 35(25):2934-2941. PubMed ID: 28727518 [TBL] [Abstract][Full Text] [Related]
12. Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1. Ramkissoon LA; Horowitz PM; Craig JM; Ramkissoon SH; Rich BE; Schumacher SE; McKenna A; Lawrence MS; Bergthold G; Brastianos PK; Tabak B; Ducar MD; Van Hummelen P; MacConaill LE; Pouissant-Young T; Cho YJ; Taha H; Mahmoud M; Bowers DC; Margraf L; Tabori U; Hawkins C; Packer RJ; Hill DA; Pomeroy SL; Eberhart CG; Dunn IF; Goumnerova L; Getz G; Chan JA; Santagata S; Hahn WC; Stiles CD; Ligon AH; Kieran MW; Beroukhim R; Ligon KL Proc Natl Acad Sci U S A; 2013 May; 110(20):8188-93. PubMed ID: 23633565 [TBL] [Abstract][Full Text] [Related]
13. Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas. Horbinski C; Hamilton RL; Nikiforov Y; Pollack IF Acta Neuropathol; 2010 May; 119(5):641-9. PubMed ID: 20044755 [TBL] [Abstract][Full Text] [Related]
14. A comprehensive analysis identifies BRAF hotspot mutations associated with gliomas with peculiar epithelial morphology. Hatae R; Hata N; Suzuki SO; Yoshimoto K; Kuga D; Murata H; Akagi Y; Sangatsuda Y; Iwaki T; Mizoguchi M; Iihara K Neuropathology; 2017 Jun; 37(3):191-199. PubMed ID: 27792249 [TBL] [Abstract][Full Text] [Related]
15. Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas. Horbinski C; Nikiforova MN; Hagenkord JM; Hamilton RL; Pollack IF Neuro Oncol; 2012 Jun; 14(6):777-89. PubMed ID: 22492957 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures. Johnson A; Severson E; Gay L; Vergilio JA; Elvin J; Suh J; Daniel S; Covert M; Frampton GM; Hsu S; Lesser GJ; Stogner-Underwood K; Mott RT; Rush SZ; Stanke JJ; Dahiya S; Sun J; Reddy P; Chalmers ZR; Erlich R; Chudnovsky Y; Fabrizio D; Schrock AB; Ali S; Miller V; Stephens PJ; Ross J; Crawford JR; Ramkissoon SH Oncologist; 2017 Dec; 22(12):1478-1490. PubMed ID: 28912153 [TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review. Nobusawa S; Hirato J; Yokoo H Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241 [TBL] [Abstract][Full Text] [Related]
18. Molecular Alterations in Pediatric Low-Grade Gliomas That Led to Death. Ahrendsen JT; Sinai C; Meredith DM; Malinowski SW; Cooney TM; Bandopadhayay P; Ligon KL; Alexandrescu S J Neuropathol Exp Neurol; 2021 Nov; 80(11):1052–1059. PubMed ID: 34580728 [TBL] [Abstract][Full Text] [Related]
19. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas. Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165 [TBL] [Abstract][Full Text] [Related]
20. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study. Marko NF; Prayson RA; Barnett GH; Weil RJ Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]